opnt003
Generic: nasal nalmefene·Code: OPNT003
opnt003: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| OPIANT PHARMACEUTICALS, INC. (OPNT) | Phase 3 |
Get deeper analysis on opnt003
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis